Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis-Reference-Cited by-同舟云学术

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis

Published:2004-06 Issue:12 Volume:116 Page:816-828
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Auerbach Andrew D.,Sanders Gillian D.,Hambleton Julie

Publisher

Elsevier BV

Subject

General Medicine

Reference72 articles.

1. Centers for Medicare and Medicaid Services. MEDPAR Inpatient Hospital Fiscal Year 2000. Available at: http://cms.hhs.gov/statistics/medpar/shtstay00drg.pdf. Accessed January 21, 2004

2. Antiphospholipid syndrome and thrombosis;Bick;Semin Thromb Hemost,1999

3. Protein C deficiency in a controlled series of unselected outpatients;Koster;Blood,1995

4. Antiphospholipid antibodies and thrombosis;Salem;Lupus,1996

5. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group;Schulman;Am J Med,1998

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypercoagulable states associated with chronic venous insufficiency;Venous Ulcers;2023

2. A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations;PharmacoEconomics;2022-07-30

3. Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations;The Pharmacogenomics Journal;2021-06-15

4. Integrated Management Approach to Atrial Fibrillation Care: A Cost Utility Analysis;Canadian Journal of Cardiology;2019-09

5. Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome;Tuberculosis and Respiratory Diseases;2019